Frontlight ResearchEarly access
Pancreatic cancer trials in South Korea
55 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peoplePancreatic Cancer Detection Consortium
- Where
- Seoul
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT06388967 - Phase 1/2Taking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - Phase 2Taking peopleA Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Seoul
- Age
- 18 years and over
- People
- 39 worldwide
- Run by
- BicycleTx Limited
See details and how to joinNCT07450859 - Phase 1/2Taking peopleA Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 102
- Run by
- GI Innovation, Inc.
See details and how to joinNCT07172802 - Phase 1Taking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Guro-gu, Jongno-gu, Seocho-gu, Seodaemun-gu, Seongnam-si
- Age
- 18 years and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - Phase 1Not yet taking people in South KoreaSKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- SK Life Science, Inc.
See details and how to joinNCT07812805 - No phaseTaking peopleComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Where
- Goyang-si, Seoul
- Age
- 50 years to 75 years
- People
- 770 worldwide
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT04239573 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Cheongju-si, Goyang-si, Seoul
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 1Taking peopleA Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- PAQ Therapeutics, Inc.
See details and how to joinNCT07300150 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Goyang-si, Seongnam, Seoul
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - Phase 1Taking peopleA First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
- Where
- Seongnam, Seoul
- Age
- 19 years and over
- People
- 51
- Run by
- Dong-A ST Co., Ltd.
See details and how to joinNCT07481357 - Phase 1/2Taking peopleStudy to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
- Where
- Gyeonggi-do, Seoul
- Age
- 19 years to 79 years
- People
- 71
- Run by
- Onconic Therapeutics Inc.
See details and how to joinNCT05257993 - Phase 2Taking peopleEfficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients
- Where
- Seoul
- Age
- 19 years and over
- People
- 60
- Run by
- Inkeun Park
See details and how to joinNCT06893783 - Phase 1/2Taking peopleThe KN510713 Study in Combination With mFOLFIRINOX
- Where
- Goyang-si
- Age
- 19 years to 75 years
- People
- 30
- Run by
- New Cancer Cure-Bio Co.,Ltd.
See details and how to joinNCT07114861 - Phase 4Taking peopleEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Where
- Busan, Chuncheon, Gwangju, Seongnam-si, Seoul
- Age
- 18 years to 64 years
- People
- 2,076 worldwide
- Run by
- Guerbet
See details and how to joinNCT04373564 - Phase 2Taking peoplePULSAR in Systemic Therapy for Pancreatic Cancer
- Where
- Seoul
- Age
- 19 years and over
- People
- 47
- Run by
- Samsung Medical Center
See details and how to joinNCT07269626 - Phase 2Taking peopleCarbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer
- Where
- Seoul
- Age
- 20 years and over
- People
- 33
- Run by
- Yonsei University
See details and how to joinNCT07257523 - Phase 2Enrolling by invitationPatients With High-grade Pancreatic Neuroendocrine Tumors
- Where
- Goyang-si
- Age
- 19 years and over
- People
- 46
- Run by
- National Cancer Center, Korea
See details and how to joinNCT07121478 - No phaseEnrolling by invitationDevelopment & Clinical Application of K-PaC Registry Version 2.0
- Where
- Goyang
- Age
- 19 years and over
- People
- 6,923
- Run by
- National Cancer Center, Korea
See details and how to joinNCT07171515 - No phaseTaking peopleDiagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
- Where
- Seoul
- Age
- 19 years and over
- People
- 1,200
- Run by
- Yonsei University
See details and how to joinNCT07035587 - No phaseTaking peopleEarly Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
- Where
- Seoul
- Age
- 19 years and over
- People
- 263 worldwide
- Run by
- Do Hyun Park
See details and how to joinNCT07030348 - Phase 2Taking peopleTripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
- Where
- Goyang-si
- Age
- 19 years and over
- People
- 98
- Run by
- National Cancer Center, Korea
See details and how to joinNCT06135896 - Phase 1/2Taking peopleEvaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer
- Where
- Seoul
- Age
- 20 years to 80 years
- People
- 75
- Run by
- BeyondBio Inc.
See details and how to joinNCT03579836 - Phase 3Taking peopleNeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
- Where
- Seoul
- Age
- 19 years to 80 years
- People
- 609
- Run by
- Seoul National University Hospital
See details and how to joinNCT05529940